Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Durand

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Urology|June 4, 2021
Active Surveillance for Biopsy Proven Renal Oncocytomas: Outcomes and FeasibilityFrancois-Xavier Deledalle, Damien Ambrosetti, Mathieu Durand, et al.
BJU International|January 22, 2013
Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control studyYann Neuzillet, Michel Soulie, Stéphane Larre, et al.
European Radiology|July 19, 2023
Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablationRaphaël Lehrer, Francois Cornelis, Jean-Christophe Bernhard, et al.
Minerva Urology and Nephrology|September 20, 2023
Can Simplified PADUA Renal (SPARE) Nephrometry scoring system help predict renal function outcomes after robot-assisted partial nephrectomy? (UroCCR study 93)Clément Klein, Gaelle Margue, Cécile Champy, et al.
Annals of Surgical Oncology|July 3, 2022
Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82)Thomas Tabourin, Ugo Pinar, Jerome Parra, et al.
The French Journal of Urology|April 4, 2025
Effect of obesity on histological type of renal tumor: The Uroccr study 69Léa Montalvan, Jean-Christophe Bernhard, Karim Bensalah, et al.
European Urology Open Science|March 18, 2024
The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional StudyRaphael Fleury, Théophile Bertail, Karim Bensalah, et al.
Nature Biotechnology|January 3, 2024
Discovery of sparse, reliable omic biomarkers with StablJulien Hédou, Ivana Marić, Grégoire Bellan, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
Annals of Surgical Oncology|June 8, 2011
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyMorgan Rouprêt, Sarah J Drouin, Stéphane Larré, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Urology|June 4, 2021
Active Surveillance for Biopsy Proven Renal Oncocytomas: Outcomes and FeasibilityFrancois-Xavier Deledalle, Damien Ambrosetti, Mathieu Durand, et al.
BJU International|January 22, 2013
Positive surgical margins and their locations in specimens are adverse prognosis features after radical cystectomy in non-metastatic carcinoma invading bladder muscle: results from a nationwide case-control studyYann Neuzillet, Michel Soulie, Stéphane Larre, et al.
European Radiology|July 19, 2023
Minimally invasive nephron-sparing treatments for T1 renal cell cancer in patients over 75 years: a comparison of outcomes after robot-assisted partial nephrectomy and percutaneous ablationRaphaël Lehrer, Francois Cornelis, Jean-Christophe Bernhard, et al.
Minerva Urology and Nephrology|September 20, 2023
Can Simplified PADUA Renal (SPARE) Nephrometry scoring system help predict renal function outcomes after robot-assisted partial nephrectomy? (UroCCR study 93)Clément Klein, Gaelle Margue, Cécile Champy, et al.
Annals of Surgical Oncology|July 3, 2022
Impact of Renal Cell Carcinoma Histological Variants on Recurrence After Partial Nephrectomy: A Multi-Institutional, Prospective Study (UROCCR Study 82)Thomas Tabourin, Ugo Pinar, Jerome Parra, et al.
The French Journal of Urology|April 4, 2025
Effect of obesity on histological type of renal tumor: The Uroccr study 69Léa Montalvan, Jean-Christophe Bernhard, Karim Bensalah, et al.
European Urology Open Science|March 18, 2024
The Impact of Histological Variants on Oncological Outcomes After Surgical Resection of a Nonmetastatic Renal Cell Carcinoma with Tumor Thrombus: A Multi-institutional StudyRaphael Fleury, Théophile Bertail, Karim Bensalah, et al.
Nature Biotechnology|January 3, 2024
Discovery of sparse, reliable omic biomarkers with StablJulien Hédou, Ivana Marić, Grégoire Bellan, et al.
European Urology Focus|January 19, 2021
Prognostic Impact of pT3 Subclassification in a Multicentre Cohort of Patients with Urothelial Carcinoma of the Renal Pelvicalyceal System Undergoing Radical Nephroureterectomy: A Propensity Score-weighted Analysis After Central Pathology ReviewThomas Seisen, Andrea Mari, Riccardo Campi, et al.
Annals of Surgical Oncology|June 8, 2011
Oncologic outcomes and survival in pT0 tumors after radical cystectomy in patients without neoadjuvant chemotherapy: results from a large multicentre collaborative studyMorgan Rouprêt, Sarah J Drouin, Stéphane Larré, et al.
Pageof 6